Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
A 2025 head-to-head clinical trial comparing FDA-approved tirzepatide to FDA-approved semaglutide for obesity found that tirzepatide produced greater reductions in body weight over 72 weeks
Only change your dosage in close partnership with your doctor, and know that theres no guarantee that youll have success with a smaller dose, even after some trial and error
Does Medicare cover Wegovy, Zepbound, and other weight-loss medications
If your weight changed alongside perimenopause or menopause, and you'd rather have one set of providers handling the hormones and the weight together, Josie's GLP-1 program for menopause starts with a short intake
10 Conclusion GLP-1 RAs have substantially advanced pharmacological treatment for obesity, offering robust efficacy with a favorable safety profile
US$ 26.72
US$ 27.14
US$ 28.80
US$ 22.03
